Literature DB >> 15940086

Predictors of elevated B-type natriuretic peptide concentrations in dyspneic patients without heart failure: an analysis from the breathing not properly multinational study.

Cathrine W Knudsen1, Paul Clopton, Arne Westheim, Tor Ole Klemsdal, Alan H B Wu, Philippe Duc, James McCord, Richard M Nowak, Judd E Hollander, Alan B Storrow, William T Abraham, Peter A McCullough, Alan S Maisel, Torbjørn Omland.   

Abstract

STUDY
OBJECTIVE: B-type natriuretic peptide (BNP) is an established tool for the diagnosis of acute congestive heart failure in patients presenting with dyspnea. Some patients have moderately elevated BNP levels (ie, 100 to 500 pg/mL) in the absence of acute congestive heart failure. The objective of the current study was to identify independent predictors of elevated BNP concentrations in the absence of congestive heart failure.
METHODS: We studied 781 patients without acute congestive heart failure and BNP levels 0 to 500 pg/mL drawn from a cohort of 1,586 patients with acute dyspnea who had BNP levels measured on emergency department arrival. Two cardiologists blinded to BNP results reviewed all clinical data and categorized patients according to whether they had acute congestive heart failure or not.
RESULTS: Independent predictors of elevated BNP levels (ie, >100 pg/mL) were a medical history of atrial fibrillation, radiographic cardiomegaly, decreased blood hemoglobin concentration, decreased body mass index, and increased age.
CONCLUSION: Knowledge of these commonly obtained variables should aid clinicians in the interpretation of moderately elevated BNP results in patients presenting with acute dyspnea in the emergency department.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15940086     DOI: 10.1016/j.annemergmed.2005.01.027

Source DB:  PubMed          Journal:  Ann Emerg Med        ISSN: 0196-0644            Impact factor:   5.721


  14 in total

1.  High-Sensitive Troponin T and N-Terminal Pro B-Type Natriuretic Peptide for Early Detection of Stress-Induced Cardiomyopathy in Patients with Subarachnoid Hemorrhage.

Authors:  J Oras; C Grivans; K Dalla; E Omerovic; B Rydenhag; S-E Ricksten; H Seeman-Lodding
Journal:  Neurocrit Care       Date:  2015-10       Impact factor: 3.210

2.  Diagnostic accuracy of tissue Doppler echocardiography for patients with acute heart failure.

Authors:  C-H Huang; M-S Tsai; C-C Hsieh; T-D Wang; W-T Chang; W-J Chen
Journal:  Heart       Date:  2006-06-27       Impact factor: 5.994

3.  The predictive value of physical examination findings in patients with suspected acute heart failure syndrome.

Authors:  Timothy B Jang; Chandra Aubin; Rosanne Naunheim; Lawrence M Lewis; Amy H Kaji
Journal:  Intern Emerg Med       Date:  2011-11-18       Impact factor: 3.397

4.  Correlates of N-terminal prohormone brain natriuretic peptides in African Americans with hypertensive chronic kidney disease: the African American Study of Kidney Disease and Hypertension.

Authors:  S Yi; G Contreras; E R Miller; L J Appel; B C Astor
Journal:  Am J Nephrol       Date:  2008-09-29       Impact factor: 3.754

5.  Relations of biomarkers of distinct pathophysiological pathways and atrial fibrillation incidence in the community.

Authors:  Renate B Schnabel; Martin G Larson; Jennifer F Yamamoto; Lisa M Sullivan; Michael J Pencina; James B Meigs; Geoffrey H Tofler; Jacob Selhub; Paul F Jacques; Philip A Wolf; Jared W Magnani; Patrick T Ellinor; Thomas J Wang; Daniel Levy; Ramachandran S Vasan; Emelia J Benjamin
Journal:  Circulation       Date:  2010-01-04       Impact factor: 29.690

6.  B-type natriuretic peptide in anesthesia practice to predict adverse cardiovascular outcomes.

Authors:  Gyu-Sam Hwang
Journal:  Korean J Anesthesiol       Date:  2011-07-17

7.  Natriuretic peptides: Diagnostic and therapeutic use.

Authors:  Kaushik Pandit; Pradip Mukhopadhyay; Sujoy Ghosh; Subhankar Chowdhury
Journal:  Indian J Endocrinol Metab       Date:  2011-10

8.  The Importance of Amino-terminal pro-Brain Natriuretic Peptide Testing in Clinical Cardiology.

Authors:  Van Kimmenade
Journal:  Biomark Insights       Date:  2007-02-07

9.  Midregional pro-adrenomedullin in addition to b-type natriuretic peptides in the risk stratification of patients with acute dyspnea: an observational study.

Authors:  Mihael Potocki; Tobias Breidthardt; Tobias Reichlin; Nils G Morgenthaler; Andreas Bergmann; Markus Noveanu; Nora Schaub; Heiko Uthoff; Heike Freidank; Lorenz Buser; Roland Bingisser; Michael Christ; Alexandre Mebazaa; Christian Mueller
Journal:  Crit Care       Date:  2009-07-23       Impact factor: 9.097

10.  Upper Reference Limits for High-Sensitivity Cardiac Troponin T and N-Terminal Fragment of the Prohormone Brain Natriuretic Peptide in Patients With CKD.

Authors:  Nisha Bansal; Leila R Zelnick; Christie M Ballantyne; Paulo H M Chaves; Robert H Christenson; Josef Coresh; Christopher R deFilippi; James A de Lemos; Lori B Daniels; Alan S Go; Jiang He; S Susan Hedayati; Kunihiro Matsushita; Vijay Nambi; Michael G Shlipak; Jonathan J Taliercio; Stephen L Seliger
Journal:  Am J Kidney Dis       Date:  2021-07-19       Impact factor: 8.860

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.